Spread This NewsBy Thandiwe Garusa PERSONS with albinism in Zimbabwe continue to die as they face severe lack of access to critical healthcare and resources, an activist has said. Marvellous Tshuma, ...
A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the ...
Nov. 19, 2024 — A study provides insights into the diversity of cancer-associated fibroblasts in white and black skin cancer and describes their different immunomodulatory roles in the tumor ...